BioCentriq is a boutique, New Jersey-based CDMO for cell and gene therapy, focusing on all stages of process development and clinical manufacturing.
With over 70 scientists, engineers, analysts, and manufacturing specialists, we have established quality systems and expertise to support the release of both autologous and allogeneic drug products.
BioCentriq also specializes in viral vector process development and manufacturing and has expertise in a variety of cell and vector types.
Our 35,000 square feet of facilities include five ISO-7 certified GMP manufacturing suites, a fully equipped process development laboratory, quality control and analytical method development laboratories, and training facilities. Visit www.biocentriq.com to learn more.